Specify a stock or a cryptocurrency in the search bar to get a summary
Nexalin Technology Inc.
NXLNexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas. Address: 1776 Yorktown, Houston, TX, United States, 77056
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NXL
Dividend Analytics NXL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NXL
Stock Valuation NXL
Financials NXL
Results | 2019 | Dynamics |